Acta Haematologica · 2010 · 12 citations · 19 references
MedicineGeneticsObstetricsHigh-risk PregnancyHuman GeneticsMedical GeneticsCoagulation AbnormalitiesCoagulation DisordersCoagulation Factor DeficienciesGenetic DisordersPlacental AbruptionThrombotic DisordersFactor Ii MutationFactor V Leiden ThrombophiliaFactor V MutationGenetic ThrombophiliaInherited Coagulation Factor DeficienciesMutationProthrombin G20210a MutationThrombophilia In Pregnancy
AIMS: Our objectives were to assess inherited thrombophilia and non-O blood group for the risk of gestational vascular complications among the Tunisian population. METHODS: This study comprised 203 test subjects with adverse pregnancy outcomes including recurrent pregnancy loss, intra-uterine growth retardation, pre-eclampsia and placental abruption. Each subgroup was matched with 100 controls and analyzed separately. All patients were evaluated for factor V Leiden, factor II G20210A mutations and for non-O blood group. Protein S, protein C and antithrombin levels were determined and deficiencies noted. RESULTS: The factor V Leiden mutation, non-O blood group and protein C deficiency had the highest incidences among patients both as a whole and in the 4 subgroups. The factor II G20210A mutation, protein S and antithrombin deficiencies were not statistically significant risk factors. CONCLUSION: Our results provide evidence for a significant association between the factor V mutation and placental abruption. Furthermore, we found that this and the non-O blood group independently increased the risk for intra-uterine growth retardation in our population.
19
VENOUS THROMBOEMBOLIC DISEASE AND ABO BLOOD TYPE
Hershel Jick, B Westerholm, MartinP. Vessey et al. · The Lancet · 1969 · 314 citations